Case Study

Helping Life Sciences Companies Speed Up Veeva Vault Validation

Overview

For life sciences organizations, validating Veeva Vault applications is essential to maintain compliance and ensure quality. However, traditional validation methods are often time-consuming, require significant manual effort, and can delay project timelines.

Spotline’s V-Assure helps pharmaceutical, biotechnology, medical device, and contract research organizations automate and simplify the Veeva Vault validation process - allowing teams to release faster while staying compliant.

The Challenge

A growing life sciences company was preparing for regular Veeva Vault updates and new feature releases. Their quality and IT teams faced several common challenges:

  • Manual execution of hundreds of validation test cases
  • Lengthy validation cycles that delayed deployments
  • Repetitive documentation and evidence collection
  • High dependency on skilled validation resources
  • Pressure to maintain GxP compliance and be audit-ready
  • Rising validation costs with every Veeva release

The organization needed a smarter, faster approach that would reduce effort without compromising regulatory requirements.

The Solution

Spotline implemented V-Assure, an AI-powered validation automation platform designed specifically for Veeva Vault.

With V-Assure, the customer was able to:

  • AI-Powered Test Script Generation
    V-Assure uses AI to automatically generate test scripts based on Veeva configurations and business requirements, eliminating the need for manual scripting. This helps validation teams significantly reduce preparation time while improving consistency and coverage. Spotline states that customers can achieve up to an 80% reduction in testing time through automation.
  • Parallel Test Execution
    Instead of validating applications sequentially, V-Assure executes tests across multiple environments and Vault applications in parallel. This reduces validation cycles from weeks to days and contributes to up to 80% faster validation cycles, enabling organizations to adopt Veeva releases more quickly.
  • Automated Evidence Collection & Audit-Ready Reporting
    The platform automatically captures screenshots, timestamps, logs, and system responses during execution and compiles them into audit-ready validation packages. This minimizes manual documentation effort and supports regulatory inspections with complete traceability.
  • Integration with Veeva Validation Management
    V-Assure integrates directly with Veeva Validation Management, providing a single source of truth for validation plans, protocols, execution results, and evidence. This eliminates manual handoffs and improves end-to-end traceability across validation activities.
  • Reusable Validation Assets Across the Veeva Landscape
    The solution provides reusable automated test libraries that can be applied across Quality, Clinical, Regulatory, Safety, and Commercial Vault applications. Spotline has completed 300+ Veeva validations and supports 12+ Veeva applications, demonstrating scalability across enterprise environments.
  • Continuous Regression Testing
    V-Assure supports continuous validation by automatically re-running regression tests after configuration changes or platform updates. In one published example, the platform automated more than 500 test case executions across Veeva Basics applications and supported multiple release cycles with pre-validation.
  • Reduced Manual Validation Effort
    By automating protocol generation, execution, and evidence capture, organizations can substantially reduce repetitive work for validation teams. Spotline reports around a 40% reduction in validation effort through automation and risk-based prioritization.
  • Enterprise-Scale Adoption
    The platform is designed for organizations running multiple Veeva applications and is described by Spotline as being trusted by 8 of the top 10 global pharmaceutical companies, with 50+ deployments worldwide and support for Quality, Clinical, Regulatory, Safety, and Commercial Vault domains.
  • Proven Compliance Outcomes
    Organizations using V-Assure benefit from automated, traceable validation processes designed for regulated environments. Spotline highlights Zero Critical Audit Findings across its V-Assure-powered validation programs and emphasizes audit-ready evidence generation for inspections

By combining automation, AI-driven capabilities, reusable assets, and deep Veeva expertise, Spotline enabled the customer to transform validation from a slow, manual process into a faster, scalable, and audit-ready operation. The result was improved productivity, quicker release readiness, and stronger confidence in regulatory compliance across the entire Veeva landscape.

Conclusion

For life sciences companies, validation should enable innovation - not slow it down. Spotline’s V-Assure empowers organizations to automate Veeva Vault validation, reduce manual work, and deliver compliant releases faster.

By replacing manual validation with intelligent automation, the customer was able to:

  • Accelerate Veeva Vault release cycles
  • Reduce manual testing effort and operational overhead
  • Produce audit-ready documentation with greater consistency
  • Improve overall efficiency across quality and validation teams
  • Maintain confidence in GxP compliance while supporting business growth

The result: a more efficient validation process, improved team productivity, and greater confidence in every Veeva deployment.